O2h Ventures

o2h Ventures is a UK-based venture capital firm founded in Cambridge that focuses on early-stage investments in biotechnology, life sciences, and AI-enabled drug discovery companies. It operates as part of the broader o2h group and typically invests in SEIS and EIS-eligible companies, particularly in therapeutics, drug discovery, and biotech platforms. The firm combines investment activity with incubation and hands-on support, often working closely with scientific founders and university spinouts. Its portfolio includes early-stage biotech companies across oncology, neuroscience, and genomics, with a strong focus on UK life sciences ecosystems such as Cambridge. o2h Ventures positions itself as a specialist deep-tech and biotech investor with an integrated model spanning discovery, incubation, and venture funding.